News
SRTS
5.94
-5.11%
-0.32
Weekly Report: what happened at SRTS last week (0513-0517)?
Weekly Report · 1d ago
Weekly Report: what happened at SRTS last week (0506-0510)?
Weekly Report · 05/13 12:04
Sensus Healthcare Price Target Raised to $10.00/Share From $8.00 by HC Wainwright & Co.
Dow Jones · 05/13 11:14
Sensus Healthcare Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 05/13 11:14
HC Wainwright & Co. Maintains Buy on Sensus Healthcare, Raises Price Target to $10
Benzinga · 05/13 11:04
SENSUS HEALTHCARE, INC. <SRTS.O>: H.C. WAINWRIGHT RAISES TARGET PRICE TO $10 FROM $8
Reuters · 05/13 10:09
U.S. RESEARCH ROUNDUP-AMC Networks, Permian Resources, Vital Energy
Wall Street securities analysts revise their ratings and price targets on several companies. AMC Networks, Permian Resources and Vital Energy are among the companies. American Airlines, UnitedHealth Group and American Airlines among those with new coverage. The analysts revised ratings and targets on the companies on Monday.
Reuters · 05/13 06:59
NVAX, GRPN and MVIS among mid-day movers
Seeking Alpha · 05/10 16:57
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Diodes Incorporated fell 9.8% to $68.99 on Friday. The company reported worse-than-expected quarterly financial results. Novavax, Inc. Shares jumped 139% after the company announced a co-exclusive licensing agreement with Sanofi.
Benzinga · 05/10 16:44
12 Health Care Stocks Moving In Friday's Intraday Session
Novavax stock increased by 110.7% to $9.42 during Friday's regular session. Novavax's, Q1 earnings came out today. ITeos Therapeutics (NASDAQ:ITOS) stock rose 46.92% during the regular session to $17.91. Sensus Healthcare stock moved upwards by 37.87%.
Benzinga · 05/10 16:31
Sensus Healthcare Price Target Raised to $10.00/Share From $7.00 by Maxim Group
Dow Jones · 05/10 15:19
Sensus Healthcare Is Maintained at Buy by Maxim Group
Dow Jones · 05/10 15:19
Maxim Group Maintains Buy on Sensus Healthcare, Raises Price Target to $10
Benzinga · 05/10 15:09
Novavax, Macrogenics, Biofrontera among healthcare movers
Healthcare On the Move: Novavax, Macrogenics, Biofrontera among healthcare movers. S&P 500 Health Care Sector +0.12% to 1670.59. Pharmaceuticals, Biotechnology & Life Science contributes 58% to index.
Seeking Alpha · 05/10 14:00
Why Natera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Shares of Natera, Inc. Rose 15.3% in today's pre-market trading after the company reported strong first-quarter earnings. Novavax shares jumped 165% to $11.84 in pre- market trading. The company posted a GAAP loss of 56 cents per share compared to market expectations for a loss of 71.
Benzinga · 05/10 12:44
12 Health Care Stocks Moving In Friday's Pre-Market Session
Aethlon Medical (NASDAQ:AEMD) stock moved upwards by 129.0% to $2.7 during Friday's pre-market session. Novavax shares rose 119.23% and Natera shares rose 20.31% during the same time period. Sensus Healthcare and XTL Biopharmaceuticals also moved upwards. Losers Macrogenics and Progyny stock declined by 67.0%.
Benzinga · 05/10 12:07
BUZZ-U.S. STOCKS ON THE MOVE-Novavax, Cummins, Hyatt Hotels
U.S. Stock index futures rise on Friday ahead of speeches from Federal Reserve officials. Economic data this week has supported bets of US interest rate cuts and lifted investor sentiment. Novavax, Cummins and Hyatt Hotels are among the top stocks on the day.
Reuters · 05/10 11:48
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Novavax stock is rocketing more than 112% alongside its Q1 earnings report and a deal with Sanofi. Earnings reports continue to be a major mover of shares this morning as companies report their Q1 2024 results. The biggest pre-market stock movers include Novavax and AEye.
Investorplace · 05/10 11:30
SRTS Stock Earnings: Sensus Healthcare Beats EPS, Beats Revenue for Q1 2024
Sensus Healthcare reported earnings per share of 14 cents for the first quarter of 2024. The company reported revenue of $10.66 million. This was 158.81% better than the analyst estimate of $4.12 million. Sensus Healthcare also reported results for the fourth quarter of 2015.
Investorplace · 05/10 01:57
Sensus Healthcare Shares Rally on Better-Than-Expected 1Q Results
Sensus Healthcare shares rose 38% in after-market trading. The medical device company's first quarter results were better than expected. The stock was recently trading at $5.24. Shares were up about 61% this year from Thursday's close. Sensus said revenue gains reflected higher radiotherapy unit sales.
Dow Jones · 05/09 22:43
More
Webull provides a variety of real-time SRTS stock news. You can receive the latest news about Sensus Healthcare Inc through multiple platforms. This information may help you make smarter investment decisions.
About SRTS
Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.